| MIRUM PHARMACEUTICALS |
| USA |
| Gesundheit |
| US6047491013 / A2PM29 |
| 08D (Frankfurt) / MIRM (NASDAQ) |
| FRA:08D, ETR:08D, 08D:GR, NASDAQ:MIRM |
| - |
| https://mirumpharma.com/ |
|
Mirum Pharmaceuticals Inc. is a biopharmaceutical company focused on developing and commercializing innovative therapies for rare diseases. Its primary objective is to address unmet medical needs, particularly in the sphere of liver diseases where fe..
>Volltext.. |
| 5531.13 Mio. EUR |
| 5477.16 Mio. EUR |
| 493.97 Mio. EUR |
| -39.07 Mio. EUR |
| -692.77 Mio. EUR |
| -11.79 EUR |
| 280.79 Mio. EUR |
| 281.76 Mio. EUR |
| -148.27 Mio. EUR |
| 1.42 |
| 40.64% |
| -867.17% |
| - |
| - |
| - |
| 3 Insider verkauften innerhalb der letzten 30 Tage Aktien im Wert von 2.813.668 Euro. |
| MIRUM |
| 06.08.26 |
|